Yunnan Dongjun Pharmaceutical Co., Ltd.
Yunnan Dongjun Pharmaceutical Co., Ltd., commonly referred to as Dongjun Pharmaceutical, is a prominent player in the pharmaceutical industry, headquartered in China. Established in 2001, the company has made significant strides in the development and production of traditional Chinese medicine and modern pharmaceuticals, primarily serving the Yunnan province and expanding its reach across various regions in China. Dongjun Pharmaceutical is renowned for its unique formulations that blend ancient herbal practices with contemporary scientific methods. The company’s core product offerings include a range of herbal extracts and health supplements, which are distinguished by their high quality and efficacy. With a commitment to innovation and quality, Dongjun has positioned itself as a trusted name in the market, achieving notable recognition for its contributions to health and wellness.
DitchCarbon Score
How does Yunnan Dongjun Pharmaceutical Co., Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Yunnan Dongjun Pharmaceutical Co., Ltd.'s score of 10 is higher than 75% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Yunnan Dongjun Pharmaceutical Co., Ltd.'s reported carbon emissions
Yunnan Dongjun Pharmaceutical Co., Ltd., headquartered in China, currently does not have available data on carbon emissions, as no specific emissions figures have been provided. Consequently, there are no reported Scope 1, 2, or 3 emissions data to analyse. Additionally, the company has not outlined any formal reduction targets or climate commitments, which limits the ability to assess their environmental impact or sustainability initiatives. In the context of the pharmaceutical industry, it is increasingly important for companies to establish clear climate strategies and emissions reduction goals to align with global sustainability efforts.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Yunnan Dongjun Pharmaceutical Co., Ltd. is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
